PAIA
ELV icon

Park Avenue Institutional Advisers’s Elevance Health ELV Stock Holding History

Park Avenue Institutional Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,645
Closed -$216K – 134
2016
Q2 		$216K Hold
1,645
– – 0.19% 128
2016
Q1 		$229K Sell
1,645
-46
-3% -$6.15K 0.2% 124
2015
Q4 		$236K Sell
1,691
-49
-3% -$6.75K 0.2% 126
2015
Q3 		$244K Sell
1,740
-59
-3% -$8.87K 0.22% 114
2015
Q2 		$295K Buy
+1,799
New +$287K 0.24% 106

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Park Avenue Institutional Advisers's ELV Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 1,645 shares — an estimated $216K sold.

Park Avenue Institutional Advisers first reported a position in ELV in Q2 2015 and held it in 5 quarters. The position peaked at $295K in Q2 2015. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 1,645 Elevance Health shares in Q3 2016, an estimated $216K.
  • Park Avenue Institutional Advisers first reported a position in Elevance Health in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Elevance Health position peaked at $295K in Q2 2015.
  • 737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.